KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBT Margin (2016 - 2025)

Quest Diagnostics (DGX) has disclosed EBT Margin for 17 consecutive years, with 11.76% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 35.0% to 11.76% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 11.94% through Dec 2025, up 4.0% year-over-year, with the annual reading at 11.94% for FY2025, 4.0% up from the prior year.
  • EBT Margin hit 11.76% in Q4 2025 for Quest Diagnostics, up from 11.65% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 32.04% in Q2 2021 to a low of 4.67% in Q4 2022.
  • Historically, EBT Margin has averaged 14.52% across 5 years, with a median of 13.06% in 2023.
  • Biggest five-year swings in EBT Margin: surged 1808bps in 2021 and later crashed -1887bps in 2022.
  • Year by year, EBT Margin stood at 18.29% in 2021, then plummeted by -74bps to 4.67% in 2022, then skyrocketed by 122bps to 10.36% in 2023, then increased by 10bps to 11.41% in 2024, then increased by 3bps to 11.76% in 2025.
  • Business Quant data shows EBT Margin for DGX at 11.76% in Q4 2025, 11.65% in Q3 2025, and 13.91% in Q2 2025.